Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Feb 25, 2019 at 12:25 PM EST

Which Gene Therapy Companies May Be Most Valuable After Spark Therapeutics Buyout

Spark Therapeutics shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of…

Chris Lange | Feb 25, 2019 at 10:20 AM EST

Is Roche Spending Too Much for Spark Therapeutics?

Spark Therapeutics shares more than doubled to start out the week after the company announced that it would be acquired…

Paul Ausick | Feb 25, 2019 at 9:55 AM EST

What Danaher Gets by Paying $21.4 Billion for GE Biopharma Business

Medical device maker Danaher has agreed to acquire GE's biopharma business for $21.4 billion in cash. The transaction is expected…

Chris Lange | Feb 25, 2019 at 9:45 AM EST

What Ipsen Wants From Clementia Pharmaceuticals

Clementia Pharmaceuticals has entered into an agreement to be acquired by French pharmaceutical company Ipsen.

Chris Lange | Feb 22, 2019 at 10:05 AM EST

Why This New Collaboration Is Incredible for Voyager Therapeutics

Voyager Therapeutics shares made an incredible gain on Friday after the firm announced a collaboration with pharma giant AbbVie.

Trey Thoelcke | Feb 22, 2019 at 8:00 AM EST

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a…

Chris Lange | Feb 21, 2019 at 9:55 AM EST

Is Merck Overpaying for Immune Design?

Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some…

Chris Lange | Feb 20, 2019 at 12:20 PM EST

Who’s to Blame for the US Opioid Epidemic

For more than half a decade, the United States has seen an incredible rise of an opioid epidemic within its…

Chris Lange | Feb 19, 2019 at 9:50 AM EST

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment

Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid…

Douglas A. McIntyre | Feb 15, 2019 at 6:25 AM EST

Trump Is Obese, Like 93 Million Other Americans

President Donald Trump had his annual physical. He weighs 243 pounds and stands six feet and three inches tall. That…

Chris Lange | Feb 13, 2019 at 10:40 AM EST

Huge Johnson & Johnson Acquisition Targets Robotics

On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused…

Chris Lange | Feb 13, 2019 at 9:15 AM EST

What Held Back Teva in Q4

Teva released mixed fourth-quarter financial results before the markets opened on Wednesday and its shares pulled back.

Chris Lange | Feb 12, 2019 at 9:55 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data…

Jon C. Ogg | Feb 12, 2019 at 9:50 AM EST

Why Gilead’s Pain Is Intercept’s Gain

It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for…

Chris Lange | Feb 12, 2019 at 9:35 AM EST

Major Pharma Scares Off Short Sellers

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 105 106 107 108 109 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Which Gene Therapy Companies May Be Most Valuable After Spark Therapeutics Buyout

Is Roche Spending Too Much for Spark Therapeutics?

What Danaher Gets by Paying $21.4 Billion for GE Biopharma Business

What Ipsen Wants From Clementia Pharmaceuticals

Why This New Collaboration Is Incredible for Voyager Therapeutics

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Is Merck Overpaying for Immune Design?

Who’s to Blame for the US Opioid Epidemic

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment

Trump Is Obese, Like 93 Million Other Americans

Huge Johnson & Johnson Acquisition Targets Robotics

What Held Back Teva in Q4

Short Sellers Run for Cover From Major Biotechs

Why Gilead’s Pain Is Intercept’s Gain

Major Pharma Scares Off Short Sellers

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

American Families’ Net Worth Jumped 37% Since 2019, But Their Paychecks Barely Moved

ExxonMobil Crushes Q1 2026 EPS Estimates by 15% — Here’s What Investors Need to Know

Tech Giants Prop Up Nasdaq Composite as Oil Shock Tests Market Resilience

American Families' Net Worth Jumped 37% Since 2019, But Their Paychecks Barely Moved

"Sitting on a Tax Time Bomb": Jim Saulnier's Warning to Retiree With $2 Million

80% of Americans want Wall Street banned from buying single-family homes. Here’s what could actually happen after November.

American Families’ Net Worth Jumped 37% Since 2019, But Their Paychecks Barely Moved

Health and Healthcare Articles

All Health and Healthcare Articles

Which Gene Therapy Companies May Be Most Valuable After Spark Therapeutics Buyout

Is Roche Spending Too Much for Spark Therapeutics?

What Danaher Gets by Paying $21.4 Billion for GE Biopharma Business

What Ipsen Wants From Clementia Pharmaceuticals

Why This New Collaboration Is Incredible for Voyager Therapeutics

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Is Merck Overpaying for Immune Design?

Who’s to Blame for the US Opioid Epidemic

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment

Trump Is Obese, Like 93 Million Other Americans

Huge Johnson & Johnson Acquisition Targets Robotics

What Held Back Teva in Q4

Short Sellers Run for Cover From Major Biotechs

Why Gilead’s Pain Is Intercept’s Gain

Major Pharma Scares Off Short Sellers

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

American Families’ Net Worth Jumped 37% Since 2019, But Their Paychecks Barely Moved

ExxonMobil Crushes Q1 2026 EPS Estimates by 15% — Here’s What Investors Need to Know

Tech Giants Prop Up Nasdaq Composite as Oil Shock Tests Market Resilience

Featured Reads

American Families' Net Worth Jumped 37% Since 2019, But Their Paychecks Barely Moved

"Sitting on a Tax Time Bomb": Jim Saulnier's Warning to Retiree With $2 Million